ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Schisandrol B protects against cholestatic liver injury by inhibiting pyroptosis through pregnane X receptor

Liang, Hangfei; Yang, Xiao; Li, Huilin; Wang, Xinhui; Su, Haiguo; Li, Xuan; Tian, Jianing; Cai, Chenghui; Huang, Min*; Bi, Huichang*南方医科大学; 中山大学
Biochemical Pharmacology2022-10DOI: 10.1016/j.bcp.2022.115222
5被引11阅读
引用收藏
分享

摘要

Previously, we demonstrated that Schisandrol B (SolB) protected against lithocholic acid (LCA)-induced cholestatic liver injury (CLI) through pregnane X receptor (PXR). Additionally, growing evidence has revealed that pyroptosis is involved in CLI. Whether the hepatoprotective effect of SolB driven by PXR activation is related to pyroptosis in CLI remains unclear. First, the hepatoprotective effect of SolB was confirmed, as evidenced by the decreased mortality, morphological and histopathological changes, and biochemical parameters. The upregulated serum lactic dehydrogenase (LDH) level, increased number of TUNEL-positive cells, and formation of hepatocyte membrane pores induced by LCA were significantly alleviated after SolB pretreatment, indicating that SolB attenuated LCA-induced hepatocyte damage. Further analysis revealed that both NOD-like receptor protein 3 (NLRP3) inflammasome-induced canonical pyroptosis and apoptosis protease activating factor-1 (Apaf-1) pyroptosome-induced noncanonical pyroptosis were significantly inhibited after SolB pretreatment, as illustrated by the decreased expression levels of NLRP3, ASC, caspase-1, and GSDMD and the levels of Apaf-1, caspase-11 p20, caspase-3 p20, and GSDME. Furthermore, the activation of the NF-kappa B and FoxO1 signaling pathways was inhibited after SolB pretreatment. In addition, the activation of PXR via SolB was proven by luciferase reporter gene assays and the upregulation of PXR targets. The results illustrated that SolB could significantly inhibit NLRP3 inflammasome-induced canonical pyroptosis through the PXR/NF-kappa B/NLRP3 axis and inhibit Apaf-1 pyroptosome-induced noncanonical pyroptosis through the PXR/FoxO1/Apaf-1 axis. Collectively, this study revealed that SolB protected against CLI by inhibiting pyroptosis through PXR, providing new insights for understanding the molecular mechanism of SolB as a promising anti-cholestatic agent.

学科与关键词

关键词
Schisandrol BCholestatic liver injuryPregnane X receptorPyroptosisNOD-like receptor protein 3Apoptotic protease activating factor-1
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Biochemical Pharmacology
发表日期
2022-10
卷期
第 204 卷
页码
115222
DOI
10.1016/j.bcp.2022.115222
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation of China [82025034, 82000593, 81973392, 82020108031]; National Key Research and Development Program [2017YFE0109900]; Shenzhen Science and Technology Program [KQTD20190929174023858]; 111 project [B16047]; Key Laboratory Foundation of Guangdong Province [2017B030314030]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01Y093]; China Postdoctoral Science Foundation [2019TQ0398, 2020M673028]

作者

  • L

    Liang, Hangfei (第一作者)

    new · sun yat sen univ

  • Y

    Yang, Xiao

    new · southern med univ

查看全部 10 位作者收起作者
  • L

    Li, Huilin

    new · sun yat sen univ

  • W

    Wang, Xinhui

    sun yat sen univ

  • S

    Su, Haiguo

    new · sun yat sen univ

  • L

    Li, Xuan

    new · sun yat sen univ

  • T

    Tian, Jianing

    new · sun yat sen univ

  • C

    Cai, Chenghui

    new · sun yat sen univ

  • H

    Huang, Min (通讯)

    new · sun yat sen univ

  • B

    Bi, Huichang (通讯)

    new · sun yat sen univ · southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417